Polycystic kidney disease in a Himalayan-Persian crossbreed cat
Downloads
Polycystic Kidney Disease (PKD) is a genetic disorder caused by mutations in PKD1, predominantly found in Persian cats. This case study reports the incidence of PKD in a Himalayan-Persian crossbreed cat treated with fluid therapy, renal supplementation, nutritional management, and red mold rice. A 5-year-old spayed female Himalayan-Persian breed cat was brought to the Kassiti Vetcare Veterinary Clinic, Bandung, complaining of decreased appetite for a week, unwilling-ness to eat for four days, abdominal pain, and orange urine. Hyperchromic macrocytic anemia was observed in a complete blood test. Blood chemistry examination revealed increased creatinine levels (363.1 µmol/L), indicating impaired renal function. Ultrasound examination showed that the kidneys were enlarged, the border between the cortex and medulla was unclear, and hypo-to-anechoic cysts of various sizes were observed in the renal cortex-medulla area. The patient was diagnosed with PKD and had poor prognosis. Treatment included intravenous (IV) Ringer’s lactate fluid therapy, RenaCor® renal supplement, Flozindo® red mold rice (RMR), and NatureBridge® for cat kidney. The patient’s condition improved after treatment, as indicated by her active condition and normal urine color.
Bilgen N, Bişkin Türkmen M, Çınar Kul B, Isparta S, ŞenY, Akkurt M, Çıldır ÖŞ, Bars Z. 2020. Prevalence of PKD1 gene mutation in cats in Turkey and pathogenesis of feline polycystic kidney disease. Journal of Veterinary Diagnostic Investigation. 32(4):549-555. https://doi.org/10.1177/1040638720935433 | PMid:32687010 PMCid:PMC7438651
Chakrabarti S, Syme HM, Elliott J. 2012. Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease. Journal of Veterinary Internal Medicine. 26(2):275-281. https://doi.org/10.1111/j.1939-1676.2011.00874.x | PMid:22269057
Collins S. 2016. The role of nutrition in the management of cats and dogs with renal disease. Veterinary Nursing Journal. 31(8):237-240. https://doi.org/10.1080/17415349.2016.1194634
Darawiroj D, Choisunirachon N. 2019. Morphological assessment of cat kidneys using computed tomography. Anatomia Histologia Embryologia. 48(4):358-365. https://doi.org/10.1111/ahe.12448 | PMid:31106459
Elliott J, Gregory FG, Jodi LW. 2017. BSAVA Manual of Canine and Feline Nephrology and Urology 3rd Edition. BSAVA, UK.
Fagundes RAB, Soder TF, Grokoski KC, Benetti F, Hack Mendes R. 2018. Probiotics in the treatment of chronic kidney disease: A systematic review. Brazilian Journal of Nephrology. 40(3):278-286. https://doi.org/10.1590/2175-8239-jbn-3931 | PMid:29958304 PMCid:PMC6533949
Huang HW, Chen MJ. 2024. Exploring the preventive and therapeutic mechanisms of probiotics in chronic kidney disease through the gut-kidney axis. Journal Agricultural Food Chemistry. 72(15):8347-8364. https://doi.org/10.1021/acs.jafc.4c00263 | PMid:38571475 PMCid:PMC11036402
Langston C, Gordon D. 2021. Effects of IV fluids in dogs and cats with kidney failure. Frontiers in Veterinary Sciences. 8(4):1-8. https://doi.org/10.3389/fvets.2021.659960 | PMid:33959654 PMCid:PMC8093391
Liu WC, Tomino Y, Lu KC. 2018. Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120. Toxins. 10(9):1-22. https://doi.org/10.3390/toxins10090367 | PMid:30208594 PMCid:PMC6162782
Nururrozi A, Sampaguita AL, Widyarini S, Indarjulianto S. 2021. Clinical and hematological features of polycystic kidney disease on a Persian cat. Veterinary Practitioner. 22(2):49-51.
Scherk M. 2014. Feline polycystic kidney disease. Clinician's Brief. [Feb 2 2025] Feline Polycystic Kidney Disease (cliniciansbrief.com).
Sim Lam PPL, Reduan MFH, Jasni S, Shaari R, Shaharulnizim N, Nordin ML, Abd Rahman A, Roslan NS. 2020. Poly-cystic kidney disease concurrent with feline parvovirus and bacterial infections in domestic shorthair cat: A case report. Comparative Clinical Pathology. 29:1283-1287. https://doi.org/10.1007/s00580-020-03170-4 | PMid:33013278 PMCid:PMC7521566
Suganya M, Nanthini AUR, Rajasekar A, Nandini MS, Lavanya G, Almutairi BO, Arunkumar P, Narenkumar J. 2023. Antihyper-lipidemic effect of red fermented rice with Monascus sp. in rats model with hematological and histopathological studies. Biomass Conversation and Biorefinery. 1-10. https://doi.org/10.1007/s13399-023-04368-6
All articles published in this journal are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0).
This license permits use, distribution, reproduction, and adaptation in any medium, including for commercial purposes, provided the original work is properly cited, a link to the license is given, and any changes made are indicated. Any derivative work must be distributed under the same license or a compatible license.




